United Capital Financial Advisors’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-12,905
| Closed | -$962K | – | 1248 |
|
2021
Q1 | $962K | Sell |
12,905
-115
| -0.9% | -$8.57K | 0.01% | 681 |
|
2020
Q4 | $2.22M | Buy |
13,020
+889
| +7% | +$152K | 0.01% | 486 |
|
2020
Q3 | $1.71M | Sell |
12,131
-920
| -7% | -$130K | 0.01% | 534 |
|
2020
Q2 | $2.09M | Sell |
13,051
-2,063
| -14% | -$331K | 0.02% | 505 |
|
2020
Q1 | $1.48M | Buy |
+15,114
| New | +$1.48M | 0.01% | 550 |
|
2019
Q4 | – | Sell |
-15,223
| Closed | -$1.15M | – | 1399 |
|
2019
Q3 | $1.15M | Sell |
15,223
-400
| -3% | -$30.1K | 0.01% | 702 |
|
2019
Q2 | $2.37M | Buy |
15,623
+643
| +4% | +$97.7K | 0.02% | 568 |
|
2019
Q1 | $1.79M | Buy |
14,980
+288
| +2% | +$34.3K | 0.01% | 616 |
|
2018
Q4 | $1.6M | Sell |
14,692
-5,535
| -27% | -$604K | 0.01% | 609 |
|
2018
Q3 | $3.27M | Sell |
20,227
-90
| -0.4% | -$14.5K | 0.02% | 508 |
|
2018
Q2 | $2.69M | Sell |
20,317
-5,794
| -22% | -$766K | 0.02% | 527 |
|
2018
Q1 | $1.94M | Sell |
26,111
-10
| -0% | -$741 | 0.01% | 599 |
|
2017
Q4 | $1.48M | Buy |
26,121
+650
| +3% | +$36.8K | 0.01% | 677 |
|
2017
Q3 | $1.16M | Buy |
25,471
+13
| +0.1% | +$589 | 0.01% | 737 |
|
2017
Q2 | $858K | Hold |
25,458
| – | – | 0.01% | 803 |
|
2017
Q1 | $754K | Hold |
25,458
| – | – | 0.01% | 820 |
|
2016
Q4 | $698K | Sell |
25,458
-1
| -0% | -$27 | 0.01% | 847 |
|
2016
Q3 | $1.56M | Sell |
25,459
-4,585
| -15% | -$281K | 0.02% | 653 |
|
2016
Q2 | $571K | Hold |
30,044
| – | – | 0.01% | 879 |
|
2016
Q1 | $586K | Hold |
30,044
| – | – | 0.01% | 831 |
|
2015
Q4 | $1.16M | Hold |
30,044
| – | – | 0.01% | 654 |
|
2015
Q3 | $965K | Hold |
30,044
| – | – | 0.01% | 702 |
|
2015
Q2 | $914K | Buy |
30,044
+833
| +3% | +$25.3K | 0.01% | 743 |
|
2015
Q1 | $356K | Buy |
+29,211
| New | +$356K | ﹤0.01% | 1019 |
|